An External Validation Study of the Oakland and Glasgow-Blatchford Scores for Predicting Adverse Outcomes of Acute Lower Gastrointestinal Bleeding in an Asian Population
Table 2
Demographic and clinical characteristics of patients in the study.
Characteristics
Age, median (interquartile range)
60 (48-71)
Sex
Male, (%)
202 (48.8)
Female, (%)
212 (51.2)
Participating site
Gia-Dinh People’s Hospital, (%)
74 (17.9)
Cho-Ray Hospital, (%)
111 (26.8)
Dong-Nai General Hospital, (%)
43 (10.4)
Can-Tho Central Hospital, (%)
55 (13.4)
Bạch-Mai Hospital, (%)
51 (12.3)
Hue Central Hospital, (%)
40 (9.6)
Da-Nang General Hospital, (%)
40 (9.6)
Previous admission with ALGIB, (%)
115 (27.8)
Comorbidities
Congestive heart failure, (%)
12 (2.9)
Ischemic heart disease, (%)
42 (10.1)
Chronic obstructive pulmonary disease, (%)
6 (1.4)
Chronic liver disease, (%)
37 (8.9)
Chronic kidney disease, (%)
26 (6.3)
Stroke or transient ischemic attack, (%)
15 (3.6)
Cancer, (%)
38 (9.2)
Hypertension, (%)
147 (35.5)
Diabetes, (%)
45 (10.9)
Preadmission medications
Aspirin, (%)
20 (4.8)
Clopidogrel, (%)
22 (5.3)
Dual antiplatelet, (%)
8 (1.9)
Warfarin, (%)
2 (0.5)
NOAC, (%)
5 (1.2)
Corticosteroid, (%)
9 (2.2)
NSAIDs, (%)
30 (7.2)
Presenting signs and symptoms
Heart rate (beat per minute)
86 (80-92)
Systolic blood pressure (mmHg)
120 (110-130)
Melena, (%)
64 (15.4)
Syncope, (%)
2 (0.5)
Blood on DRE, (%)
260 (62.8)
Laboratory data at admission
Hematocrit (%)
31.8 (24.5-38.4)
Hemoglobin (g/L)
103 (76-126)
Platelet (×103/μL)
242 (191-311)
INR
1.06 (1.00-1.15)
Blood urea nitrogen (mg/dL)
14.2 (11-21)
Creatinine (μmol/L)
0.93 (0.79-1.14)
Types of lower gastrointestinal endoscopy
Colonoscopy, (%)
264 (63.8)
Sigmoidoscopy, (%)
78 (18.8)
Rectoscopy, (%)
68 (16.4)
Enteroscopy, (%)
5 (1.2)
Abdominal CT scan, (%)
80 (19.3)
Data are (%) or median (interquartile range). NOAC: novel oral anticoagulant; NSAIDs: nonsteroidal anti-inflammatory; DRE: digital rectal examination.
